NCT00560118 2025-02-14
MGFOT1
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Terminated
Clinical Trials
8 trialsNCT01359956 2023-04-11
SICOG 0109
National Cancer Institute, Naples
Phase 3 Completed
NCT01069627 2018-12-06
A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma
Hoffmann-La Roche
Phase 2 Completed
NCT01474239 2016-03-15
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Hoffmann-La Roche
Phase 2 Completed
NCT01983124 2016-01-20
BeyPro1
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 2 Completed
NCT02460068 2015-06-02
NIBIT-M2
Italian Network for Tumor Biotherapy Foundation
Phase 3 Unknown
NCT01654692 2015-05-13
NIBIT-M1
Italian Network for Tumor Biotherapy
Phase 2 Completed
NCT00110123 2012-09-24
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated